Opportunity

SAM #36E79726Q0005

National Contract for Roflumilast Tablets for Federal Healthcare Agencies

Buyer

VA National Acquisition Center Pharmaceuticals

Posted

September 09, 2026

Respond By

September 17, 2026

Identifier

36E79726Q0005

NAICS

325412

This opportunity involves a national contract for Roflumilast Tablets to support multiple federal healthcare agencies. - Government Buyer: - Department of Veterans Affairs (VA), NAC Pharmaceuticals office - Contract Specialist: Kenneth Lay - Agencies served: VA, Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), Federal Health Care Center (FHCC) - Products Requested: - Roflumilast Tablets in all strengths and sizes - Specific line items: - ROFLUMILAST 250MCG TAB (28 tablets per bottle, 11,870 bottles) - ROFLUMILAST 500MCG TAB (30 tablets per bottle, 18,916 bottles) - ROFLUMILAST 500MCG TAB (90 tablets per bottle, 13,880 bottles) - OEMs and Vendors: - No specific manufacturers or OEMs named; offerors must provide unique NDCs - Notable Requirements: - Unique eleven-digit National Drug Code (NDC) for each product, with the first five digits identifying the offeror - Contractor's label with unique NDC must be the only label on the product - Unit of use packaging with child-proof bottles required - If not the manufacturer, a letter of commitment from the manufacturer is required - Chargeback agreements with Pharmaceutical Prime Vendors (PPVs) for timely distribution - Contract Structure: - Base year plus up to four option years - NAICS code: 325412 (Pharmaceutical Preparation Manufacturing)

Description

I am conducting market research for the procurement of Roflumilast Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:

Is your Company able to meet the following minimum requirements:

           

National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor’s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________          

If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________

Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________

Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________

Under NAICS code 325412, is your company size (check one):

Large Business ______

Small Business ______

If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________

Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________

Can your company meet the following product, bottle size and usage? Please indicate any details or comments.

___________________________________________________________

___________________________________________________________

View original listing